| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $344K | -96.8% |
| Cost of Revenue | $10.6M | -42.7% |
| Gross Profit | -$10.2M | +20.2% |
| R&D Expense | $8.3M | +145.5% |
| SG&A Expense | $14.9M | +43.0% |
| Operating Income | -$41.8M | -26.2% |
| Net Income | -$39.5M | +93.5% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | +105.8% |
| Short-term Investments | $27.7M | -62.8% |
| Accounts Receivable | $26K | — |
| Inventory | $18.7M | +126.8% |
| Current Assets | $65.7M | -28.8% |
| Total Assets | $107.5M | -2.3% |
| Current Liabilities | $14.5M | +58.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.3M | -15.1% |
| Capital Expenditures | $12.4M | +76.8% |
| Investing Cash Flow | $36.1M | +143.5% |
| Financing Cash Flow | $15.5M | -85.1% |
| Free Cash Flow | -$50.7M | -25.8% |
| Total Liabilities |
| $25.2M |
| +105.3% |
| Stockholders' Equity | $82.3M | -15.8% |